These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1449968)

  • 1. In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a review.
    Newell DR; Maxwell RJ; Golding BT
    NMR Biomed; 1992; 5(5):273-8. PubMed ID: 1449968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic studies with the antifolate C2-desamino-C2-methyl-N10-propargyl-2'-trifluoromethyl-5,8-dideazafolic acid (CB3988) in mice and rats using in vivo 19F-NMR spectroscopy.
    Newell DR; Maxwell RJ; Bisset GM; Jodrell DI; Griffiths JR
    Br J Cancer; 1990 Nov; 62(5):766-72. PubMed ID: 2245168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 19F nuclear magnetic resonance imaging of drug distribution in vivo: the disposition of an antifolate anticancer drug in mice.
    Maxwell RJ; Frenkiel TA; Newell DR; Bauer C; Griffiths JR
    Magn Reson Med; 1991 Jan; 17(1):189-96. PubMed ID: 2067393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Jackman AL; Newell DR; Gibson W; Jodrell DI; Taylor GA; Bishop JA; Hughes LR; Calvert AH
    Biochem Pharmacol; 1991 Oct; 42(10):1885-95. PubMed ID: 1741766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidylate synthase: a target for anticancer drug design.
    Harrap KR; Jackman AL; Newell DR; Taylor GA; Hughes LR; Calvert AH
    Adv Enzyme Regul; 1989; 29():161-79. PubMed ID: 2633608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy.
    Griffiths JR; Glickson JD
    Adv Drug Deliv Rev; 2000 Mar; 41(1):75-89. PubMed ID: 10699306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position.
    Jackman AL; Marsham PR; Thornton TJ; Bishop JA; O'Connor BM; Hughes LR; Calvert AH; Jones TR
    J Med Chem; 1990 Nov; 33(11):3067-71. PubMed ID: 2231607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 19F MRS studies of fluoropyrimidine chemotherapy. A review.
    McSheehy PM; Griffiths JR
    NMR Biomed; 1989 Nov; 2(4):133-41. PubMed ID: 2701569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacology of anticancer agents. (Part 1) Introduction, alkylating agents and platinum compounds].
    Fujita H
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2481-7. PubMed ID: 1952967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolates.
    Bisset GM; Pawelczak K; Jackman AL; Calvert AH; Hughes LR
    J Med Chem; 1992 Mar; 35(5):859-66. PubMed ID: 1372358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinazoline antifolate thymidylate synthase inhibitors: nitrogen, oxygen, sulfur, and chlorine substituents in the C2 position.
    Marsham PR; Chambers P; Hayter AJ; Hughes LR; Jackman AL; O'Connor BM; Bishop JA; Calvert AH
    J Med Chem; 1989 Mar; 32(3):569-75. PubMed ID: 2918503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potency.
    Jones TR; Thornton TJ; Flinn A; Jackman AL; Newell DR; Calvert AH
    J Med Chem; 1989 Apr; 32(4):847-52. PubMed ID: 2704030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
    Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
    Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-based inhibitors of thymidylate synthase: synthesis and antitumor activity of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Marriott JH; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1997 May; 40(10):1495-510. PubMed ID: 9154971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours.
    McSheehy PM; Port RE; Rodrigues LM; Robinson SP; Stubbs M; van der Borns K; Peters GJ; Judson IR; Leach MO; Griffiths JR
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):117-28. PubMed ID: 15592719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse.
    Newell DR; Alison DL; Calvert AH; Harrap KR; Jarman M; Jones TR; Manteuffel-Cymborowska M; O'Connor P
    Cancer Treat Rep; 1986 Aug; 70(8):971-9. PubMed ID: 3731153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.
    Becker M; Port RE; Zabel HJ; Zeller WJ; Bachert P
    J Magn Reson; 1998 Jul; 133(1):115-22. PubMed ID: 9654475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.